US$ 27.05
zepbound/mounjaro/tirzepatide F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy Tirzepatide (Mounjaro & Zepbound) for
Description
Which food ingredient companies do you think are best positioned to benefit from the GLP-1 trend

Expert UK guidance on tirzepatide safety.
Carson City, NV

DaVitas 2026 EPS guidance midpoint of $14.30 landed 13% above analyst consensus, and the compounding gets sharper from here.
